Peptidase modulation of the pulmonary effects of tachykinins.
The physiological effects of the tachykinin peptides substance P (SP) and neurokinin A (NKA) are limited by their microenvironmental degradation. We used the isolated tracheally superfused guinea pig lung to examine the importance of various degradative enzymes in limiting the physiological effects of exogenously administered and endogenously released tachykinins. When SP and NKA are administered via the airway epithelium, neutral endopeptidase (NEP; EC 3.4.24.11) is the major degradative enzyme as indicated by the effects of NEP inhibitors alone compared to the effects of a NEP inhibitor along with a cocktail of other peptidase inhibitors. The effects of enzyme inhibitors on physiological responses is mirrored in the amounts of peptide recovered from lung perfusates as determined using an enzyme-linked immunosorbent assay. We found similar effects when SP and NKA were released endogenously by the acute infusion of capsaicin. These data indicate that NEP is the predominant degradative enzyme modulating the effects of SP and NKA administered via the airways.
Martins
M A
MA
Department of Medicine, Beth Israel Hospital, Boston, Mass.
Shore
S A
SA
Drazen
J M
JM
D000818:Animals; D002216:Captopril / Q000494:pharmacology; D004151:Dipeptides / Q000494:pharmacology; D006168:Guinea Pigs; D066298:In Vitro Techniques; D008168:Lung / Q000187:drug effects*; D015260:Neprilysin / Q000502:physiology*; D015288:Neurokinin A / Q000494:pharmacology*; D010477:Perfusion; D013373:Substance P / Q000494:pharmacology*; D015244:Thiorphan / Q000494:pharmacology
D004151:Dipeptides; D013373:Substance P; C062344:SCH 32615; D015288:Neurokinin A; D002216:Captopril; D015244:Thiorphan; D015260:Neprilysin